Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Non-Current Deffered Revenue (2016 - 2022)

Veracyte's Non-Current Deffered Revenue history spans 10 years, with the latest figure at $278000.0 for Q1 2022.

  • On a quarterly basis, Non-Current Deffered Revenue fell 62.78% to $278000.0 in Q1 2022 year-over-year; TTM through Mar 2022 was $278000.0, a 62.78% decrease, with the full-year FY2021 number at $343000.0, down 58.62% from a year prior.
  • Non-Current Deffered Revenue hit $278000.0 in Q1 2022 for Veracyte, down from $343000.0 in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for VCYT hit a ceiling of $4.1 million in Q1 2018 and a floor of $278000.0 in Q1 2022.
  • Historically, Non-Current Deffered Revenue has averaged $1.9 million across 4 years, with a median of $788000.0 in 2020.
  • Biggest five-year swings in Non-Current Deffered Revenue: dropped 6.36% in 2018 and later plummeted 62.78% in 2022.
  • Tracing VCYT's Non-Current Deffered Revenue over 4 years: stood at $3.9 million in 2018, then crashed by 78.74% to $829000.0 in 2020, then plummeted by 58.62% to $343000.0 in 2021, then decreased by 18.95% to $278000.0 in 2022.
  • Business Quant data shows Non-Current Deffered Revenue for VCYT at $278000.0 in Q1 2022, $343000.0 in Q4 2021, and $552000.0 in Q3 2021.